205 related articles for article (PubMed ID: 38566107)
1. Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers.
Bukato K; Kostrzewa T; Gammazza AM; Gorska-Ponikowska M; Sawicki S
Cell Commun Signal; 2024 Apr; 22(1):205. PubMed ID: 38566107
[TBL] [Abstract][Full Text] [Related]
2. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
Cavalieri E; Rogan E
Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
[TBL] [Abstract][Full Text] [Related]
3. Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.
Brinton LA; Trabert B; Anderson GL; Falk RT; Felix AS; Fuhrman BJ; Gass ML; Kuller LH; Pfeiffer RM; Rohan TE; Strickler HD; Xu X; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1081-9. PubMed ID: 27197275
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.
Yager JD
Steroids; 2015 Jul; 99(Pt A):56-60. PubMed ID: 25159108
[TBL] [Abstract][Full Text] [Related]
5. Endogenous estrogen metabolites as biomarkers for endometrial cancer via a novel method of liquid chromatography-mass spectrometry with hollow fiber liquid-phase microextraction.
Zhao H; Jiang Y; Liu Y; Yun C; Li L
Horm Metab Res; 2015 Feb; 47(2):158-64. PubMed ID: 24722971
[TBL] [Abstract][Full Text] [Related]
6. Endogenous estrogens as carcinogens through metabolic activation.
Yager JD
J Natl Cancer Inst Monogr; 2000; (27):67-73. PubMed ID: 10963620
[TBL] [Abstract][Full Text] [Related]
7. Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase.
Salama SA; Kamel M; Awad M; Nasser AH; Al-Hendy A; Botting S; Arrastia C
Int J Cancer; 2008 Sep; 123(6):1246-54. PubMed ID: 18566989
[TBL] [Abstract][Full Text] [Related]
8. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
9. The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk.
Williams-Brown MY; Salih SM; Xu X; Veenstra TD; Saeed M; Theiler SK; Diaz-Arrastia CR; Salama SA
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):78-86. PubMed ID: 21600284
[TBL] [Abstract][Full Text] [Related]
10. Potential mechanisms of estrogen quinone carcinogenesis.
Bolton JL; Thatcher GR
Chem Res Toxicol; 2008 Jan; 21(1):93-101. PubMed ID: 18052105
[TBL] [Abstract][Full Text] [Related]
11. Effects of estrogens and metabolites on endometrial carcinogenesis in young adult mice initiated with N-ethyl-N'-nitro-N-nitrosoguanidine.
Takahashi M; Shimomoto T; Miyajima K; Yoshida M; Katashima S; Uematsu F; Maekawa A; Nakae D
Cancer Lett; 2004 Jul; 211(1):1-9. PubMed ID: 15194211
[TBL] [Abstract][Full Text] [Related]
12. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
13. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.
Yue W; Santen RJ; Wang JP; Li Y; Verderame MF; Bocchinfuso WP; Korach KS; Devanesan P; Todorovic R; Rogan EG; Cavalieri EL
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):477-86. PubMed ID: 14623547
[TBL] [Abstract][Full Text] [Related]
14. Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery.
Audet-Delage Y; Grégoire J; Caron P; Turcotte V; Plante M; Ayotte P; Simonyan D; Villeneuve L; Guillemette C
J Steroid Biochem Mol Biol; 2018 Apr; 178():45-54. PubMed ID: 29092787
[TBL] [Abstract][Full Text] [Related]
15. Estrogen metabolism and risk of breast cancer in postmenopausal women.
Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
[TBL] [Abstract][Full Text] [Related]
16. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
Cavalieri E; Rogan E
Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
[TBL] [Abstract][Full Text] [Related]
17. The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites.
Zhu BT; Roy D; Liehr JG
Endocrinology; 1993 Feb; 132(2):577-83. PubMed ID: 8381068
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Wild MJ; Rudland PS; Back DJ
J Steroid Biochem Mol Biol; 1993 May; 45(5):407-20. PubMed ID: 8499348
[TBL] [Abstract][Full Text] [Related]
19. Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation.
Hiraku Y; Yamashita N; Nishiguchi M; Kawanishi S
Int J Cancer; 2001 May; 92(3):333-7. PubMed ID: 11291067
[TBL] [Abstract][Full Text] [Related]
20. Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort.
Dallal CM; Lacey JV; Pfeiffer RM; Bauer DC; Falk RT; Buist DS; Cauley JA; Hue TF; LaCroix AZ; Tice JA; Veenstra TD; Xu X; Brinton LA;
Horm Cancer; 2016 Feb; 7(1):49-64. PubMed ID: 26728471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
